Mackay Shields LLC’s Madrigal Pharmaceuticals MDGL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-6,261
| Closed | -$733K | – | 1064 |
|
|
2021
Q1 | $733K | Sell |
6,261
-3,467
| -36% | -$406K | 0.01% | 1095 |
|
|
2020
Q4 | $1.08M | Sell |
9,728
-2,400
| -20% | -$267K | 0.01% | 1066 |
|
|
2020
Q3 | $1.44M | Hold |
12,128
| – | – | 0.01% | 903 |
|
|
2020
Q2 | $1.37M | Buy |
12,128
+200
| +2% | +$22.7K | 0.01% | 914 |
|
|
2020
Q1 | $796K | Buy |
11,928
+1,400
| +13% | +$93.4K | 0.01% | 1018 |
|
|
2019
Q4 | $960K | Sell |
10,528
-1,200
| -10% | -$109K | 0.01% | 1076 |
|
|
2019
Q3 | $1.01M | Buy |
11,728
+1,800
| +18% | +$155K | 0.01% | 1103 |
|
|
2019
Q2 | $1.04M | Buy |
9,928
+6,967
| +235% | +$730K | 0.01% | 1114 |
|
|
2019
Q1 | $371K | Buy |
2,961
+400
| +16% | +$50.1K | ﹤0.01% | 1239 |
|
|
2018
Q4 | $289K | Buy |
2,561
+161
| +7% | +$18.2K | ﹤0.01% | 1256 |
|
|
2018
Q3 | $514K | Buy |
+2,400
| New | +$514K | ﹤0.01% | 1000 |
|